Biolargo, Inc.
BLGO· OTC
BLGOBiolargo, Inc.
Filed Nov 14, 2025 · 10-Q · 45 days after period end · 0001437749-25-035239
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $1.10M | $4.35M | $2.67M | $1.50M |
| Net Income | -$7.24M | -$1.06M | -$1.51M | -$847.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 14, 2025 · 45 d after period end
